TOP TIERMARKET NEWSWIRE
SEC Form 4 history

AVALO THERAPEUTICS I (AVTX) insider trades

AVALO THERAPEUTICS I (AVTX) insider trading activity (SEC Form 4). Over the trailing 90 days, AVTX insiders filed 0 purchases totalling $0 and 6 sales totalling $655K — net SELLING of $655K. Most recent filing: Jul 29, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
6
$655K
Net (90d)
-$655K
net selling
Most recent
Jul 29, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 29, 2026Doyle MittieChief Medical OfficerS SaleOE—$20.00$20Kfiling
Jul 2, 2026Doyle MittieChief Medical OfficerS SaleOE—$20.00$93Kfiling
Jun 25, 2026Doyle MittieChief Medical OfficerS SaleOE—$18.00$26Kfiling
Jun 1, 2026Doyle MittieChief Medical OfficerS SaleOE—$16.00$11Kfiling
May 19, 2026Doyle MittieChief Medical OfficerS SaleOE—$18.76$56Kfiling
May 11, 2026Sullivan Christopher RyanCFOS SaleOE—$24.12$449Kfiling